MedPath

Effect of painless vaginal delivery versus normal vaginal delivery on maternal and neonatal outcomes in pregnant wome

Phase 2
Conditions
Vaginal delivery.
Other obstructed labour
Registration Number
IRCT201508259014N77
Lead Sponsor
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
168
Inclusion Criteria

(a) gestational age of 37 weeks or over; (b) being eligible for vaginal delivery.
Exclusion criteria: (a) having diabetes, cardiovascular diseases, or intracranial diseases; (b) having gestational diabetes, preeclampsia, or macrosomia; (c) coagulation disorders; (d) dermal infection on the location of epidural anesthesia; (e) non-treated bacteremia.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measuring the duration of the first and second stages of vaginal delivery. Timepoint: after intervention. Method of measurement: using Friedman curve.;Measuring episiotomy pain. Timepoint: 6 and 12 hours after vaginal delivery. Method of measurement: using visual analog scale (VAS).;) assessing Apgar score. Timepoint: at the first and fifth minutes after birth. Method of measurement: through physical examination.
Secondary Outcome Measures
NameTimeMethod
Assessing hyperthermia. Timepoint: at 4, 8, and 12 hours after vaginal delivery. Method of measurement: using oral thermometer.;Assessing headache. Timepoint: 12 hours after vaginal delivery. Method of measurement: using visual analog scale (VAS).
© Copyright 2025. All Rights Reserved by MedPath